Nkarta reports fourth quarter and full year 2023 financial results and corporate highlights

South san francisco, calif., march 21, 2024 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a clinical-stage biopharmaceutical company developing engineered natural killer (nk) cell therapies, today reported financial results for the fourth quarter and year ended december 31, 2023.
NKTX Ratings Summary
NKTX Quant Ranking